Nuwellis, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
企業コードNUWE
会社名Nuwellis Inc
上場日Feb 16, 2012
最高経営責任者「CEO」Erb (John L)
従業員数38
証券種類Ordinary Share
決算期末Feb 16
本社所在地12988 Valley View Rd
都市EDEN PRAIRIE
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号55344
電話番号19523454200
ウェブサイトhttps://www.nuwellis.com/
企業コードNUWE
上場日Feb 16, 2012
最高経営責任者「CEO」Erb (John L)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし